project id: TCGA-BRCA; case submitter id: TCGA-BH-A6R8; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.91; rna integrity number: 9.0; age at index: 46; days to birth: -16829; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1966; age at diagnosis: 16829; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 293.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 260; initial weight: 170.0; sample id: 2895fe68-6ad0-4e50-af50-cec91436ddd9; sample submitter id: TCGA-BH-A6R8-01A; portion id: ff52ceeb-c75c-452e-8f93-35d4d7a8d3b7; portion submitter id: TCGA-BH-A6R8-01A-21; slide id: 0c127098-1764-4555-9588-1d2de72561a1; slide submitter id: TCGA-BH-A6R8-01A-02-TSB; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 10.0; percent stromal cells: 5.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; section location: TOP;